Psychedelic News from around the world

Filament Health Corp. Announces Private Placement for Psychedelic Drug Development

Exciting news in psychedelic drug development! Filament Health Corp. announces private placement for clinical trial...

Psychedelic Therapy Advancements: Clinics, Research, and Legislation

Exciting developments in psychedelics: Numinus Wellness focuses on clinics, Small Pharma's DMT trial shows promise,...

GH Research PLC Making Strides in Treating Treatment-Resistant Depression with Inhalable Mebufotenin

GH Research making strides in transforming treatment of psychiatric disorders with inhalable mebufotenin for treatment-resistant...

Filament Health Corp. and Negev Capital Partner for Psychedelic Clinical Trial Funding

Filament Health Corp. aims to raise C$2 million to advance their Phase 2 methamphetamine clinical...

Exciting Developments in Psychedelic Research and Regulation

Exciting developments in the psychedelic industry: clinics, DMT treatment, psilocybin laws, and challenging accepted theories....

GH Research PLC Advances Clinical Development Program for GH001 in Treating Treatment-Resistant Depression, FDA Holds IND Application

GH Research's GH001 shows promise in treating treatment-resistant depression with exciting updates on clinical development...

Filament Health Corp. Announces Private Placement Offering to Fund Phase 2 Clinical Trial for Methamphetamine Use Disorder

"Filament Health Corp. announces private placement offering to raise C$2,000,000 for psychedelic drug development."...

Exciting Developments in the World of Psychedelics: Clinics, DMT, Neuroplasticity, and Legislation

Exciting developments in psychedelics research and legislation shape the future of mental health and wellness....

“GH Research PLC Unveils Breakthrough Treatment for Treatment-Resistant Depression”

GH Research PLC announces exciting updates on their potential breakthrough treatment for treatment-resistant depression (TRD)....